A vaccine that can learn and adapt sounds like salvation. Until it starts changing more than the virus.
In a pandemic, the world does not need a miracle. It needs a result.
London, early 2020. COVID-19 is tearing through St. Margaret’s Hospital, and Dr. Sofia Mendes is running on exhaustion and instinct. Wards overflow. Supplies vanish. Patients die alone. Every shift feels like a slow disaster nobody can stop.
When lockdown hits, and the system begins to fracture, Sofia makes a decision she can’t take back. Alongside her colleague Claire Thompson, she turns a forgotten hospital room into a hidden lab, reviving her abandoned research project, Vitalis Redux, a radical decoy-protein platform designed to disrupt viral replication at its source. When Claire succumbs to the virus, grief turns Sofia’s mission into something sharper and far more aggressive.
Outmatched and under-resourced, Sofia brings in her former research partner, Dr. Jolie Harding. She draws in private investor Magnus Vale, whose funding brings speed, scale, and a level of pressure Sofia cannot control. The faster the results arrive, the less room there is for caution. Together, they attempt something unprecedented: an adaptive vaccine built to evolve alongside the virus, and whatever comes next.
Approval comes. Rollout follows. The world celebrates. Then silence. Sofia starts to see perfection in the data, suggesting the cure has not just ended an emergency, but rewriting the future.
A tense medical thriller for readers of Robin Cook and Michael Crichton, Remnavax: The Discovery is the first novel in a grounded medical thriller trilogy set in the lived reality of the COVID era, where scientific ambition collides with institutional power, and victory carries a cost no one is ready to name.
Publisher: BookFuel
"Sinopsis" puede pertenecer a otra edición de este libro.
D. K. Rivers is a London-based banker and writer whose fiction explores the intersections of memory, time, and institutional power. Drawing on a career in finance and a long-standing fascination with complex systems - both human and structural - his work examines how organizations behave under pressure, how decisions are shaped by invisible incentives, and how individual lives are altered by forces far larger than themselves.His writing is grounded in emotional realism and informed by close observation of professional environments where precision, risk, and moral ambiguity coexist. Across speculative fiction and corporate thrillers, Rivers is interested less in spectacle than in consequence: what happens after the breakthrough, after the decision, after the system declares success.Remnavax: The Discovery is the culmination of several years of research and reflection following the COVID-19 pandemic. Set in London during the earliest months of the COVID crisis, the novel blends scientific plausibility with moral urgency, exploring the human cost of innovation and the ethical fault lines brought to breaking point when institutions are forced to move faster than they were designed to. The book draws on real-world medical, regulatory, and organizational pressures while remaining firmly rooted in character and lived experience.Remnavax: The Discovery, is his first novel.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: California Books, Miami, FL, Estados Unidos de America
Condición: New. Nº de ref. del artículo: I-9781068296383
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9781068296383
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9781068296383
Cantidad disponible: Más de 20 disponibles
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. Print on Demand. Nº de ref. del artículo: 408695758
Cantidad disponible: 4 disponibles
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Condición: New. PRINT ON DEMAND. Nº de ref. del artículo: 18405507099
Cantidad disponible: 4 disponibles
Librería: Books Puddle, New York, NY, Estados Unidos de America
Condición: New. Print on Demand. Nº de ref. del artículo: 26405507089
Cantidad disponible: 4 disponibles
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Nº de ref. del artículo: C9781068296383
Cantidad disponible: Más de 20 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Hardcover. Condición: Brand New. 379 pages. 6.24x1.14x9.24 inches. In Stock. Nº de ref. del artículo: x-1068296380
Cantidad disponible: 2 disponibles
Librería: CitiRetail, Stevenage, Reino Unido
Paperback. Condición: new. Paperback. A pandemic. A breakthrough. A discovery that may change humanity forever.In this thought-provoking COVID-19 era medical thriller, a brilliant and dedicated physician finds herself at the center of a race against time to develop a groundbreaking vaccine.In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, working on the front lines in London, joins forces with immunologist Dr. Jolie Harding at the Racquers Virology Center to revive an abandoned research project known as Vitalis Redux. Instead of targeting the virus directly, the experimental approach uses molecular decoys designed to disrupt viral replication itself.As hospitals begin to collapse under the pressure of the pandemic, the team secures funding from controversial financier Magnus Vale, whose interest in the project raises troubling ethical questions. With time running out, Sofia and Jolie push forward, hoping their breakthrough will save millions.What they discover soon challenges everything they thought possible.Their vaccine candidate, REMNAVAX, does more than teach the immune system to recognize a virus. It appears capable of anticipating future mutations, dynamically adapting as viral structures evolve.At first the results look miraculous.Then they become unsettling.The immune response is not merely effective. It is flawless. Too consistent. Too complete. Patterns begin to emerge suggesting the system is learning in ways no biological model predicted.As REMNAVAX moves toward global deployment, scientific triumph collides with political pressure, corporate ambition, and the struggle to control the narrative of the greatest medical breakthrough in history.But when subtle long-term signals begin appearing in the data, Sofia realizes their discovery may have changed far more than viral immunity.Remnavax is a gripping medical thriller exploring science, power, and the hidden consequences of innovation.Perfect for readers who enjoy the high-stakes scientific suspense of Michael Crichton and Robin Cook, Remnavax blends medical realism, speculative science, and political intrigue in a story about what happens when humanity solves the wrong problem perfectly. Remnavax: The Discovery follows Dr. Sofia Mendes, a virologist turned ER doctor battling a collapsing system during COVID-19. When a buried project resurfaces, she and Jolie Harding create an adaptive vaccine that can evolve. Backed by billionaire Magnus Vale, the science advances fast, at a dangerous cost. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Nº de ref. del artículo: 9781068296383
Cantidad disponible: 1 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Buch. Condición: Neu. Neuware - A pandemic. A breakthrough. A discovery that may change humanity forever.In this thought-provoking COVID-19 era medical thriller, a brilliant and dedicated physician finds herself at the center of a race against time to develop a groundbreaking vaccine.In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, working on the front lines in London, joins forces with immunologist Dr. Jolie Harding at the Racquers Virology Center to revive an abandoned research project known as Vitalis Redux. Instead of targeting the virus directly, the experimental approach uses molecular decoys designed to disrupt viral replication itself.As hospitals begin to collapse under the pressure of the pandemic, the team secures funding from controversial financier Magnus Vale, whose interest in the project raises troubling ethical questions. With time running out, Sofia and Jolie push forward, hoping their breakthrough will save millions.What they discover soon challenges everything they thought possible.Their vaccine candidate, REMNAVAX, does more than teach the immune system to recognize a virus. It appears capable of anticipating future mutations, dynamically adapting as viral structures evolve.At first the results look miraculous.Then they become unsettling.The immune response is not merely effective. It is flawless. Too consistent. Too complete. Patterns begin to emerge suggesting the system is learning in ways no biological model predicted.As REMNAVAX moves toward global deployment, scientific triumph collides with political pressure, corporate ambition, and the struggle to control the narrative of the greatest medical breakthrough in history.But when subtle long-term signals begin appearing in the data, Sofia realizes their discovery may have changed far more than viral immunity.Remnavax is a gripping medical thriller exploring science, power, and the hidden consequences of innovation.Perfect for readers who enjoy the high-stakes scientific suspense of Michael Crichton and Robin Cook, Remnavax blends medical realism, speculative science, and political intrigue in a story about what happens when humanity solves the wrong problem perfectly. Nº de ref. del artículo: 9781068296383
Cantidad disponible: 2 disponibles